These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34565216)

  • 1. Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network.
    Chan SK; Chau SC; Chan SY; Tong CC; Lam KO; Lai-Wan Kwong D; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
    Cancer Control; 2021; 28():10732748211047117. PubMed ID: 34565216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections.
    Wang X; Sun H; Li L; Gan Z; Wu X; Du J
    BMC Cancer; 2023 Aug; 23(1):761. PubMed ID: 37587425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983-2008: suggestion of a potential protective role of oestrogen.
    Xie SH; Yu IT; Tse LA; Mang OW; Yue L
    Eur J Cancer; 2013 Jan; 49(1):150-5. PubMed ID: 22892061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).
    Au KH; Ngan RKC; Ng AWY; Poon DMC; Ng WT; Yuen KT; Lee VHF; Tung SY; Chan ATC; Sze HCK; Cheng ACK; Lee AWM; Kwong DLW; Tam AHP
    Oral Oncol; 2018 Feb; 77():16-21. PubMed ID: 29362121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secular trends of salted fish consumption and nasopharyngeal carcinoma: a multi-jurisdiction ecological study in 8 regions from 3 continents.
    Lau HY; Leung CM; Chan YH; Lee AW; Kwong DL; Lung ML; Lam TH
    BMC Cancer; 2013 Jun; 13():298. PubMed ID: 23782497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
    Chow JCH; Tam AHP; Cheung KM; Lee VHF; Chiang CL; Tong M; Wong ECY; Cheung AKW; Chan SPC; Lai JWY; Ngan RKC; Ng WT; Lee AWM; Au KH
    Oral Oncol; 2020 Dec; 111():105012. PubMed ID: 32980659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco smoking, family history, and the risk of nasopharyngeal carcinoma: a case-referent study in Hong Kong Chinese.
    Xie SH; Yu IT; Tse LA; Au JS; Lau JS
    Cancer Causes Control; 2015 Jun; 26(6):913-21. PubMed ID: 25822573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997.
    Luo J; Chia KS; Chia SE; Reilly M; Tan CS; Ye W
    Eur J Epidemiol; 2007; 22(8):513-21. PubMed ID: 17594525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality.
    Lee AW; Foo W; Mang O; Sze WM; Chappell R; Lau WH; Ko WM
    Int J Cancer; 2003 Feb; 103(5):680-5. PubMed ID: 12494479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and nasopharyngeal cancer: individual data meta-analysis of six prospective studies on 334 935 men.
    Lin JH; Wen CP; Jiang CQ; Yuan JM; Chen CJ; Ho SY; Gao W; Zhang W; Wang R; Chien YC; Xu L; Wu X; Jin YL; Koh WP; Hsu WL; Zhu F; Wen C; Zhu T; Lee JH; Mai ZM; Lung ML; Lam TH
    Int J Epidemiol; 2021 Jul; 50(3):975-986. PubMed ID: 33787881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy.
    Chow JCH; Au KH; Mang OWK; Cheung KM; Ngan RKC
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):48-55. PubMed ID: 29932287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysis.
    Fan Y; Guan W; Huang R; Lin SY; Song Y; Lu S; Kang L; Yang Q; Lang J; Zhang P
    Cancer Med; 2020 Dec; 9(24):9315-9325. PubMed ID: 33058559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological Profile and Clinicopathological, Therapeutic, and Prognostic Characteristics of Nasopharyngeal Carcinoma in Northern Morocco.
    Reffai A; Mesmoudi M; Derkaoui T; Ghailani Nourouti N; Barakat A; Sellal N; Mallick P; Bennani Mechita M
    Cancer Control; 2021; 28():10732748211050587. PubMed ID: 34664512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.
    Nicholls JM; Lee VH; Chan SK; Tsang KC; Choi CW; Kwong DL; Lam KO; Chan SY; Tong CC; So TH; Leung TW; Luk MY; Khong PL; Lee AW
    Br J Cancer; 2019 Oct; 121(8):690-698. PubMed ID: 31527689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive vitamin B6 during treatment is related to poor prognosis of patients with nasopharyngeal carcinoma: A U-shaped distribution suggests low dose supplement.
    Li H; Chen M; Liang S; Wei X; Wang R; Cui C; Ruan G; Ou Q; Liu L
    Clin Nutr; 2021 Apr; 40(4):2293-2300. PubMed ID: 33873269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
    Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
    Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.